U-Systems, a GE Healthcare Company, will showcase the first Automated Breast Ultrasound approved by the FDA for breast cancer screening as an adjunct to mammography for asymptomatic women with dense breast tissue and no prior breast interventions at the 23rd Annual National Interdisciplinary Breast Center Conference (NCoBC), March 23-27, 2013. Throughout the conference, GE Healthcare will conduct workshops to demonstrate typical ABUS exam acquisition and additionally will be hosting two educational events to introduce NCoBC attendees to ABUS.
Using proprietary technology to automate the ultrasound imaging process, the somo•v ABUS system was developed specifically for the high-volume, breast cancer screening environment. The somo•VIEWer Advanced 3D Workstation enables fast, accurate review and archiving of patient exams, optimizing breast ultrasound screening workflow. The somo•v ABUS system is the only ultrasound device approved for breast cancer screening in the United States as an adjunct to mammography for asymptomatic women with dense breast tissue.
“Designed and built specifically for screening, research shows that ABUS technology as an adjunct to mammography has the potential to find 35.7 percent additional cancers that would not have been found with mammography alone,” said Anders Wold, president and CEO, Ultrasound, GE Healthcare.”